Equity
€24,570 from €142,071 in 2015
Equity fell by 83% in 10 years.
INFIRMIERE LABAR
Lifetime
20 annual accounts with figures on one time axis, 22 filings since 2004peak €51,103 (2018)
€36,956▼ 18.0%
peak €34,734 (2024)
€27,086▼ 22.0%
peak €142,071 (2015)
€24,570▼ 48.4%
€100,747▲ 3.6%
Board1 name since 2021
1 directorBénédicte LABAR
Documentsfilings and deeds
06-06-202655 days before the deadline
2025micro format
Gross margin from €45,059 to €36,956Dividend €50,147Equity from €47,631 to €24,570Cash from €47,681 to €31,488
Key points
from the 2025 annual accountsChecked score
83
Excellent
Financially stronger than 34% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024lowest value
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.2%▲ +0.1 percentage points vs 05-2025
07-2025: 0.2%● unchanged vs 06-2025
08-2025: 0.2%● unchanged vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.3%▲ +0.1 percentage points vs 06-2026highest value
08-2026: 0.3%● unchanged vs 07-2026highest value
09-2026: 0.3%● unchanged vs 08-2026highest value
10-2026: 0.3%● unchanged vs 09-2026highest value
11-2026: 0.3%● unchanged vs 10-2026highest value
Financial strengthAverage
Score breakdown
raises risk
No registered site in the KBO
Profit of €27,086 (financial year 2025)
lowers risk
Size: total assets €125,317
Founded in 2003
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 28% of them on solvency, 21% on liquidity, 77% on profitability and 9% on growth.
The bankruptcy probability was computed on 06-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 3,818 companies had the same profile as INFIRMIERE LABAR has now. Each dot stands for 10 companies, two years later.
95.1%
were still trading
3.7%
stopped another way
1.0%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of INFIRMIERE LABAR itself: 0.3% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,818 companies, not a prediction for INFIRMIERE LABAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €2,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.24 (1.48 in 2024), below the usual 1.5. Short-term debt is 80.4% and cash 25.1% of total assets. 80.4% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-06-2026, 55 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
55 days early
2024
38 days early
2023
31 days early
2022
22 days early
2021
39 days early
2020
13 days early
2019
19 days early
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 7 accounts on average 31 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 23 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Change of role: Bénédicte LABAR, from manager to director
General meeting of 12-12-2023 · Gazette deed
Incorporation
published on 10-10-2003 · Gazette deed
Official details
Source: KBO- Status
- Active since 03-10-2003Normal situation
- Activity
- “Toutes prestations entrant dans l’exercice de la profession d’infirmière,de services de soins à domicile…” (deed in French)From the articles, 6 activitiesNo NACE code in the KBO yet
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Annual accounts 2025
- ≈ €150,000estimated
- €125,317▼ 13.5%
- Filing
- Filed on 06-06-2026, 55 days before the end of the filing period
Insights on INFIRMIERE LABAR
INFIRMIERE LABAR files the micro format. That format states no turnover. The gross margin rose from €36,516 in 2006 to €36,956 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about INFIRMIERE LABAR
- What is the company number of INFIRMIERE LABAR?
- The company number of INFIRMIERE LABAR is 0860.844.217. The VAT number is the same number with BE in front: BE 0860.844.217.
- Where is INFIRMIERE LABAR based?
- The registered office is at Rue de la Chênee 46, 5060 Sambreville.Company details
- What is the legal form of INFIRMIERE LABAR?
- INFIRMIERE LABAR is a private limited company (BV).
- When was INFIRMIERE LABAR founded?
- INFIRMIERE LABAR was founded on 03-10-2003.
- Is INFIRMIERE LABAR still active?
- Yes, INFIRMIERE LABAR is an active enterprise in the KBO register.
- What is the turnover of INFIRMIERE LABAR?
- The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €36,956 and 2,946 comparable companies of the same size. It probably lies between €89,000 and €270,000. It is a rough estimate.Financials
- Is INFIRMIERE LABAR profitable?
- In financial year 2025, INFIRMIERE LABAR made a profit of €27,086.
- Where can I find the annual accounts of INFIRMIERE LABAR?
- INFIRMIERE LABAR filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of INFIRMIERE LABAR due?
- INFIRMIERE LABAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.